SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Phase 3 FLASH2 Trial of HyBryte in CTCL is Underway On December 16, ...

Considering the totality of data from the ... or Platinum doublet (1 cycle); then platinum doublet (2 cycles) plus thoracic radiotherapy; then durvalumab (10 mg/kg Q2W for 26 cycles). KEYFORM-008 is a ...

Holoclara, a biotechnology company pioneering the development of worm-derived therapies for allergic and autoimmune disorders, today announced the selection of eosinophilic esophagitis (EoE) as its ...

With life sciences real estate looking to turn the corner in 2025, developers and landlords will find themselves struggling ...

Trial results presented at the ASH Annual Meeting 2024 could prompt changes in the treatment of CLL and SLL, experts say.

Explorance, a global leader in feedback analytics solutions, is announcing today the appointment of Shawn Overcast as General Manager of Enterprise Solutions & Thought Leadership. Shawn will oversee ...

The input of the DeepTXsolver is the parameters of the mechanism model, and the output is the corresponding stationary distribution solution of the model. The input to the DeepTXinferrer is the ...

Environmentalists say monarch populations are shrinking due to climate change, agricultural expansion and herbicides that ...

Galderma today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting the marketing ...

When it comes to developing a mobile app, finding the right company is essential to turn your ideas into reality. The UK is ...

Western Digital Corporation ( NASDAQ: WDC) Barclays 22nd Annual Global Technology Conference December 12, 2024 12:15 PM ET ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects around 30% of the global population. Studies suggest ...